Although 2024 has not seen a return to the levels of fines and outcomes of the pre-financial crisis era, there has been a notable uptick...
Freshfields Risk & Compliance
In brief: On 12 December 2024, draft legislation to amend the Medicines for Human Use (Clinical Trials) Regulations 2004 was laid before...
2024 was an eventful year for UK shareholder litigation, and 2025 looks set to bring about a number of further significant developments....
The new Labour government has placed financial services at the centre of its plans to grow the UK economy, and UK regulators have an...
In summary: The UK MHRA’s plans for reforming the medical devices regulatory framework post-Brexit have begun to take more concrete...
/Passle/5832ca6d3d94760e8057a1b6/MediaLibrary/Images/2024-12-18-20-07-15-265-67632b733e67bad811f56678.png)
We are continuing to see a significant number of large-scale tax investigations and disputes internationally, and with governments across...
The Court of Appeal’s decision On 25 October 2024, the Court of Appeal handed down its judgment in three linked appeals – Johnson v...
On 11 November 2024, an updated draft of the Short Selling Regulations 2024 was laid before Parliament, accompanied by a draft...
Finally! Avid readers of Freshfields blogs might remember from our post last autumn that the UK government and financial regulators in...
The FCA yesterday published its revised proposals to publicise enforcement investigations. Reactions to the original proposals both from...
A recent UK FCA decision highlights the FCA’s expectation that, in certain circumstances, issues relating to the conduct of senior...
Background On 14 November 2024, the High Court handed down judgment in the first substantive trial to take place in the industry-wide NOx...